PPAT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.592200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.086000E-01
Normal-vs-Stage2
6.410600E-01
Normal-vs-Stage3
5.163200E-01
Normal-vs-Stage4
1.897170E-01
Stage1-vs-Stage2
6.803400E-01
Stage1-vs-Stage3
2.572200E-01
Stage1-vs-Stage4
1.056790E-01
Stage2-vs-Stage3
2.894400E-01
Stage2-vs-Stage4
2.701200E-01
Stage3-vs-Stage4
3.650200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.489400E-01
Normal-vs-AfricanAmerican
4.390800E-01
Normal-vs-Asian
6.935400E-01
Caucasian-vs-AfricanAmerican
6.044800E-01
Caucasian-vs-Asian
3.349600E-02
AfricanAmerican-vs-Asian
8.154000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.141200E-01
Normal-vs-Female
5.980400E-01
Male-vs-Female
2.846000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.213200E-01
Normal-vs-Age(41-60Yrs)
4.813400E-01
Normal-vs-Age(61-80Yrs)
7.703200E-01
Normal-vs-Age(81-100Yrs)
7.185600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.005400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.203800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.582200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.291800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.727800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.749000E-01
Normal-vs-Daily Drinker
8.837400E-01
Normal-vs-Weekly Drinker
6.416800E-01
Normal-vs-Occasional Drinker
4.979000E-01
Normal-vs-Social Drinker
5.967400E-01
Non Drinker-vs-Daily Drinker
7.223600E-01
Non Drinker-vs-Weekly Drinker
5.565800E-01
Non Drinker-vs-Occasional Drinker
5.560400E-01
Non Drinker-vs-Social Drinker
6.672400E-01
Daily Drinker-vs-Weekly Drinker
4.290800E-01
Daily Drinker-vs-Occasional Drinker
3.303400E-01
Daily Drinker-vs-Social Drinker
4.442600E-01
Weekly Drinker-vs-Occasional Drinker
8.150800E-01
Weekly Drinker-vs-Social Drinker
7.704800E-01
Occasional Drinker-vs-Social Drinker
9.190200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.430000E-01
Normal-vs-Grade 2
6.774800E-01
Normal-vs-Grade 3
7.215600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.822300E-02
Grade 1-vs-Grade 3
6.178400E-03
Grade 1-vs-Grade 4
6.430000E-01
Grade 2-vs-Grade 3
8.202500E-02
Grade 2-vs-Grade 4
6.774800E-01
Grade 3-vs-Grade 4
7.215600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.373600E-01
Normal-vs-NonDiabetic
6.854200E-01
Diabetic-vs-NonDiabetic
2.618800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.695000E-01
Normal-vs-NoPancreatitis
6.952600E-01
Pancreatitis-vs-NoPancreatitis
2.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.683200E-01
Normal-vs-N1
6.020200E-01
N0-vs-N1
2.118400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.307800E-01
Normal-vs-TP53-NonMutant
8.002400E-01
TP53-Mutant-vs-TP53-NonMutant
1.460940E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
